Meeting Spotlight: Resolution of Inflammation and Tissue Fibrosis and Repair Joint Meetings

On June 12-16, 2022, Keystone Symposia will host joint meetings on Resolution of Inflammation and Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies, in Keystone Colorado. As joint meetings, attendees will gain access to both meetings and joint sessions to promote cross-disciplinary mechanistic insights and clinical advances.

See full program summaries and highlights below!

This conference will bring together an interdisciplinary group of scientists to explore how immune cells, stromal cells, and neural cells interact to coordinate the resolution of inflammation, and subsequent tissue repair and regeneration. These interactions and functions will be covered in the context of healthy tissue repair, as well as dysfunctional chronic and pathological inflammation.

The program will examine our current understanding of diseases that impact the resolution of inflammation, such as atherosclerosis and asthma, with the goal of conceptualizing and developing novel pro-resolution therapies to treat diseases driven by either lack of or aberrant resolution and repair responses.

Program Highlights:

• Rethinking Myeloid Cells in Resolution, Repair and Regeneration
• Stromal Cells Spanning Inflammation to Resolution (Joint Session)
• Interface of Inflammation, Resolution & Disease
• Neuroimmune Interactions in Resolution of Inflammation
• Emerging Concepts in Inflammation & Tissue Repair (Joint Session)
• Translating Inflammation and Resolution to Therapies
• Novel Approaches to Regeneration
  

Find Out More

Fibrosis is a final common pathway in many forms of organ failure and a major cause of morbidity and mortality worldwide. This conference will cover emerging molecular mechanisms driving fibrosis, aberrant fibroblast activation and inadequate tissue repair after injury.

The program will explore how novel targets and pathways relevant to human disease can be leveraged to promote tissue repair and regeneration. We aim to integrate molecular and translational research in an effort to facilitate the development of new fibrosis treatments, as well as novel diagnostic and prognostic approaches.

Program Highlights:

• Regulation of Fibrosis by Altering Senescence and Aging
• Cutting Edge Models of Fibrosis
• Fibroblast Diversity in Fibrotic Disease
• Stromal Cells Spanning Inflammation to Resolution (Joint Session)
• Next Generation Multi-Ome Technologies
• Epithelial Injury, Repair and Fibrosis
• Emerging Concepts in Inflammation and Tissue Repair (Joint Session)
• Translational Prognostic and Diagnostic Biomarker Strategies
• Fibrosis: Advances in the Development of Novel Therapies

Find Out More